UK and US Sign Pharmaceutical Trade Agreement

Analiza editoriala

Bazat pe 1 sursa, 1 articol

The agreement is expected to facilitate the faster approval of new drugs and medical devices in both the UK and the US. Proponents argue that it will boost innovation and provide patients with quicker access to life-saving treatments. However, critics raise concerns about potential impacts on drug pricing and the accessibility of affordable medications.